Hyponatremia as a risk factor for adverse outcomes of hospitalization in case of decompensated heart failure

Syrkin A.L.

doi:https://doi.org/

Syrkin A.L.

Sechenov First Moscow State Medical University

Scopus AuthorID: 7103104759
ORCID: 0000-0002-9602-292X

Hyponatremia as a risk factor for adverse outcomes of hospitalization in case of decompensated heart failure

Authors:

Syrkin A.L.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2014;7(4): 69‑74

Read: 2087 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Syrkin AL. Hyponatremia as a risk factor for adverse outcomes of hospitalization in case of decompensated heart failure. Russian Journal of Cardiology and Cardiovascular Surgery. 2014;7(4):69‑74. (In Russ.)

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)

Использование инфографики авторами научных работ

References:

Adrogue´ H.J., Madias N.E. Hyponatremia. N Engl J Med 2000; 342: 1581-1589.
Allen L. A. et al. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circulat Cardiovasc Qual Outcomes 2011; 4: 389-398.
Bettari L. et al. Hyponatremia and long-term outcomes in chronic heart failure-an observational study from the Duke Databank for Cardiovascular Diseases. J Cardiol Fail 2012; 18: 74-81.
Binanay C., Califf R.M., Hasselblad V. et al. ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation Study of Congestive Heart Failure and Pulmonary ArteryCatheterization Effectiveness: the ESCAPE trial. JAMA 2005; 294: 1625-1633.
Broce J.C., Price L.L., Liangos O., Uhlig K., Jaber B.L. Hospital-acquired acute kidney injury: an analysis of nadir-to-peak serum creatinine increments stratified by baseline estimated GFR. Clin J Am Soc Nephrol 2011; 6: 7: 1556-1565.
Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 5: 373-383.
Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity inde for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 6: 613-619.
Fang J., Mensah G.A., Croft J.B., Keenan N.L. Heart failure-related hospitalization in the U.S. 1979 to 2004. J Am Coll Cardiol 2008; 52: 6: 428-434.
Gheorghiade M., Abraham W.T., Albert N.M. et al. OPTIMIZE-HF Investigators and Coordinators.Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007; 28: 980-988.
Gheorghiade M., Gattis W.A., O'Connor C.M. et al. Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 2004; 291: 1963-1971.
Gheorghiade M., Konstam M.A., Burnett J.C. Jr. et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials. JAMA 2007; 297: 1332-1343.
Gheorghiade M., Niazi I., Ouyang J. et al. Tolvaptan Investigators. Vasopressin V2-receptor blockade with Tolvaptan in patients with chronic heart failure: results from a double-blind randomized trial. Circulation 2003; 107: 2690-2696.
Gheorghiade M., Rossi J.S., Cotts W. et al. Characterization and Prognostic Value of Persistent Hyponatremia in Patients With Severe Heart Failure in the ESCAPE Trial. Arch Intern Med 2007; 167: 1998-2005.
Gottlieb S.S., Abraham W., Butler J. et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Cardiol Fail 2002; 8: 136-141.
Hawkins R.C. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta 2003; 337: 169-172.
Hillier T.A., Abbott R.D., Barrett E.J. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med 1999; 106: 4: 399-403.
Katz M.A. Hyperglycemia-induced hyponatremia: calculation of e pected serum sodium depression. N Engl J Med 1973; 289: 16: 843-844.
Klein L., O'Connor C.M., Leimberger J.D. et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) study. Circulation 2005; 111: 2454-2460.
Konstam M., Gheorghiade M., Burnett J. et al. Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial. JAMA 2007; 297: 1319-1331.
Lee D.S., Austin P.C., Rouleau J.L. et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003; 290: 2581-2587.
Lee W.H., Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986; 73: 257-267.
Levey A.S., Stevens L.A., Schmid C.H. et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 5: 150: 9: 604-612.
McMurray J.J.V., Adamopoulos S., Anker S.D. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012; 33: 1787-1847.
Schrier R.W., Abraham W.T. N Engl J Med 1999; 341: 577-585.
Schrier R.W., Sharma S., Shchekochikhin D. Hyponatraemia: more than just a marker of disease severity? Nat Rev Nephrol 2013; 9: 1: 37-50.
Schrier R.W. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol 2006; 17: 1820-1832.
Shah M.R., O'Connor C.M., Sopko G. et al. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale. Am Heart J 2001; 141: 528-535.
Shchekochikhin D.Y., Schrier R.W., Lindenfeld J. et al. Outcome Differences in Community-versus Hospital-Acquired Hyponatremia in Patients with a Diagnosis of Heart Failure. Circulat Heart Fail 2013; 6: 3: 379-386.
Shorr A.F., Tabak Y.P., Johannes R.S., Gupta V., Saltzberg M.T., Costanzo M.R. Burden of sodium abnormalities in patients hospitalized for heart failure. Congest Heart Fail 2011; 17: 1: 1-7.